Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our Fc gamma RI / CD64 Binding Kit !
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Project Name | Project Stage | Molecule Type | Host Species | Therapeutic Area | Indications |
CLDN6 mAb - 01 | PCC | Solid Tumor | Ovarian cancer,Lung adenocarcinoma |
Expression analysis of human Claudin-6 on HEK293/Human Claudin-6 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human Claudin-6 Stable Cell Line or negative control cell using anti-human Claudin-6 antibody followed by PE anti-human IgG Fc antibody after fixation with 4% paraformaldehyde.
Flow cytometric analysis of Anti-Claudin-6 CAR-293 cells staining with Fluorescent Human Claudin-6 Full Length Protein (VLP) (Cat. No. CL6-HF2G8) (2e5 of Anti-Claudin-6 CAR-293 cells were stained with 100 μL of 3 μg/mL of Fluorescent Human Claudin-6 Full Length Protein (VLP) (Cat. No. CL6-HF2G8), compared with negative control protein analyzed with FACS (QC tested).
Anti-Claudin 6 antibody, Human IgG1 captured on Protein A Chip can bind Biotinylated Human Claudin-6 Protein, His,Avitag&Flag Tag (Cat. No. CL6-H85D3) with an affinity constant of 41.5 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
SC-004 | SC-004 | Taisho Pharmaceutical Holdings Co Ltd | Details | ||
CLDN6 CAR-T cell therapy (BioNTech) | BNT-211 | Biontech Se | Details | ||
CLDN6-CAR-NK Cell Therapy | Phase 2 Clinical | Second Affiliated Hospital Of Guangzhou Medical University | Ovarian Neoplasms; Testicular Neoplasms; Endometrial Neoplasms | Details | |
DS-9606a | DS-9606a; DS-9606-a | Phase 1 Clinical | Daiichi Sankyo Inc | Ovarian Neoplasms; Neoplasms; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal | Details |
AMG-794 | AMG-794 | Phase 1 Clinical | Amgen Inc | Carcinoma, Ovarian Epithelial; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.